Related Experiment Videos
Cytokine mRNA in Gaucher disease
M Lichtenstein1, A Zimran, M Horowitz
1Gaucher Clinic, Shaare Zedek Medical Center, Jerusalem, Israel.
Blood Cells, Molecules & Diseases
|March 28, 1998
Summary
Gaucher disease patients show increased IL-1beta mRNA expression. This suggests cytokines like Interleukin-1 beta may contribute to Gaucher disease
Area of Science:
- Biochemistry
- Genetics
- Immunology
Background:
- Gaucher disease is the most common glycolipid storage disorder, stemming from glucocerebrosidase deficiency.
- Accumulation of glucocerebrosides in macrophages characterizes the disease, leading to phenotypic heterogeneity.
- Activated Gaucher cells release cytokines (IL-1beta, IL-8, IL-6, TNF-alpha), potentially influencing disease features.
Purpose of the Study:
- To investigate cytokine mRNA expression in monocytes from Gaucher disease patients.
- To determine if specific cytokines correlate with the biochemical and clinical manifestations of Gaucher disease.
Main Methods:
- Mononuclear cells were isolated from Gaucher patients and healthy controls.
- Reverse transcription-polymerase chain reaction (RT-PCR) with semiquantitative analysis was used to measure cytokine mRNA expression.
Main Results:
- Significantly increased Interleukin-1 beta (IL-1beta) mRNA expression was observed in Gaucher patients compared to controls.
- A trend towards elevated Tumor Necrosis Factor-alpha (TNF-alpha) mRNA was noted in Gaucher patients.
- No significant differences in IL-6 or IL-8 mRNA expression were found between Gaucher patients and controls.
Conclusions:
- Elevated IL-1beta mRNA expression in Gaucher disease patients suggests a role for this cytokine in the disease's pathogenesis.
- Cytokine dysregulation, particularly IL-1beta, may contribute to the complex phenotype of Gaucher disease.